Pan-Cancer Panels For Hematologic Malignancies
DNA sequencing alone or in combination with RNA sequencing can provide valuable insight to the key genetic features involved in hematologic malignancies, especially alterations that may be less common or those that provide an opportunity for targeted therapy. We offer pan-cancer panels designed to help identify the most suitable treatment for patients with hematologic malignancies.
HEMASALUS™
Comprehensive genomic profiling for all hematologic malignancies
Hemasalus™ analyses mutations and selected translocations of 571 key genes in hematologic malignancies by targeted DNA-sequencing (Hemasalus™ D), or in combination with whole transcriptome mRNA-sequencing (Hemasalus™ DR) to detect a broader range of gene translocations and expression changes.
WHO IS IT FOR
Patients with hematologic malignancies
SAMPLE TYPES FOR LYMPHOMAS
Tumor tissue (FFPE block/slides, or frozen tissue)
Fine needle biopsy
Liquid biopsy
Peripheral blood or bone marrow
SAMPLE TYPE FOR LEUKEMIAS AND MYELOMAS
Peripheral blood or bone marrow
HEMARNA™
Targeted RNA sequencing of 400 genes for all hematologic malignancies
Hematolymphoid tumors are a group of highly heterogeneous diseases. So far, more than 100 fusion genes have been introduced in the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Fusion gene testing is crucial in diagnosis, treatment decision making, MRD monitoring and prognosis.
WHO IS IT FOR
- Early fusion screening for patients with hematolymphoid tumors (including acute lymphoblastic lymphoma, acute myeloid leukaemia, myeloproliferative neoplasms, and lymphomas)
- Patients with hematolymphoid tumors but are ‘pan-negative’ or have non-classical fusions and require further fusion testing
- Patients with specific fusion mutations undergoing dynamic monitoring after treatment or relapse
SAMPLE TYPES
Tumor tissue (FFPE block/slides, or frozen tissue)
Fine needle biopsy
Liquid biopsy (plasma and cerebrospinal fluid)
Peripheral blood or bone marrow
LET’S ACCELERATE PRECISION CANCER CARE, TOGETHER.
Learn more about our products and services or contact us today to discuss how we can partner together.
